Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Gibb

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
HIV Medicine|February 9, 2010
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell countsP Munderi, A S Walker, C Kityo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 28, 2011
Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitisH Rabie, A Violari, T Duong, et al.
AIDS and Behavior|October 21, 2016
Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan AfricaG Abongomera, A Cook, V Musiime, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trialV Mulenga, A Cook, A S Walker, et al.
AIDS (London, England)|April 13, 2004
Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcomeJ-P Aboulker, A Babiker, M L Chaix, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2010
Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adultsC Kityo, A S Walker, L Dickinson, et al.
Lancet (London, England)|November 24, 2004
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trialC Chintu, G J Bhat, A S Walker, et al.
BMJ (Clinical Research Ed.)|November 1, 2003
Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and IrelandD M Gibb, T Duong, P A Tookey, et al.
Lancet (London, England)|March 30, 2010
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohortA S Walker, D Ford, C F Gilks, et al.
Clinical Pharmacology and Therapeutics|December 23, 2011
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1P Kasirye, L Kendall, K K Adkison, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
HIV Medicine|February 9, 2010
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell countsP Munderi, A S Walker, C Kityo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 28, 2011
Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitisH Rabie, A Violari, T Duong, et al.
AIDS and Behavior|October 21, 2016
Improved Adherence to Antiretroviral Therapy Observed Among HIV-Infected Children Whose Caregivers had Positive Beliefs in Medicine in Sub-Saharan AfricaG Abongomera, A Cook, V Musiime, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2010
Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trialV Mulenga, A Cook, A S Walker, et al.
AIDS (London, England)|April 13, 2004
Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcomeJ-P Aboulker, A Babiker, M L Chaix, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2010
Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adultsC Kityo, A S Walker, L Dickinson, et al.
Lancet (London, England)|November 24, 2004
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trialC Chintu, G J Bhat, A S Walker, et al.
BMJ (Clinical Research Ed.)|November 1, 2003
Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and IrelandD M Gibb, T Duong, P A Tookey, et al.
Lancet (London, England)|March 30, 2010
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohortA S Walker, D Ford, C F Gilks, et al.
Clinical Pharmacology and Therapeutics|December 23, 2011
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1P Kasirye, L Kendall, K K Adkison, et al.
Pageof 10